Why people use GHK-Cu for wound healing
Slow-healing cut, post-procedure scar, surgical incision. GHK-Cu? The honest answer: yes, there is real clinical evidence here, not just gym-bro consensus. GHK-Cu was first identified for its wound-healing effect in human plasma (Pickart, 1973).
This page covers what's known, what's not, and what the editorial take is for normal humans considering GHK-Cu for wound healing.
What the evidence says
Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.
- GHK-Cu was first identified for its wound-healing effect in human plasma (Pickart, 1973).
- Increases collagen synthesis and reduces scar tissue formation in clinical trials.
- Used in some hospital burn protocols outside the US.
Protocol notes
Topical, applied around (not directly on) open wounds. Coordinate with the surgeon or wound-care nurse.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full GHK-Cu directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch